Maxis AI launches MaxisAI Holarchy, the first Verticalized Context Layer for life sciences.Learn More

    EventsPanel

    Event

    DIA Global Annual Meeting 2026

    Maxis AI panel: 'Governed AI in Submissions.'

    Location

    Venue announced upon registration

    Dates

    June 14–18, 2026

    Time

    9:00 AM – 5:00 PM local time

    DIA Global Annual Meeting 2026

    About this event

    Maxis AI panel: 'Governed AI in Submissions.' Join the Maxis AI team and industry peers for a focused session on how governed agentic AI is reshaping clinical operations, biometrics, and oversight across regulated R&D.

    Expect live demos, working sessions with our architects, and conversations with sponsors and CROs who have moved beyond pilots into production.

    Key takeaways

    • Live demos of agentic CDM, biometrics, and oversight in production.
    • Benchmarks on cycle time, cost, and quality from peer sponsors and CROs.
    • Direct conversations with Maxis AI architects and clinical SMEs.
    • A clear view of where governed AI fits across your operating model.
    • Curated networking with R&D, clinical, biometrics, and QA leaders.

    Meet the team

    James O'Connell

    James O'Connell

    VP, R&D Economics

    James writes about the financial mechanics of clinical trials and where AI moves the needle on per-study burn rate and submission timelines.

    Dr. Anika Rao

    Dr. Anika Rao

    Head of Clinical AI, Maxis AI

    Anika leads Maxis AI's clinical agent practice, working with sponsors and CROs on governed deployments across CDM, biometrics, and oversight.

    Marcus Lehmann

    Marcus Lehmann

    Principal, Biometrics Strategy

    Marcus has 18 years in clinical biometrics across Top-20 pharma and global CROs. He writes about agentic delivery models for SDTM, ADaM, and TLF.

    Location

    Venue announced upon registration

    Full venue details, travel guidance, and on-site logistics will be shared with all registered attendees ahead of the event.

    Who should attend

    • Heads of Clinical Operations, Data Management, and Biometrics
    • R&D, Clinical Development, and Portfolio leaders
    • QA, Compliance, and Validation leaders responsible for GxP oversight
    • Sponsor and CRO executives evaluating agentic delivery models

    Why attend

    See governed agentic AI working against real clinical workflows.

    Benchmark your program against peers from Top-20 pharma and CROs.

    Meet the Maxis AI team and explore tailored deployment paths.

    Leave with a point of view you can take back to your leadership team.